Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2005 1
2006 1
2015 1
2016 1
2018 2
2019 4
2020 1
2021 2
2022 2
2023 1
2024 2
2025 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

20 results

Results by year

Filters applied: . Clear all
Page 1
Sunitinib for metastatic progressive phaeochromocytomas and paragangliomas: results from FIRSTMAPPP, an academic, multicentre, international, randomised, placebo-controlled, double-blind, phase 2 trial.
Baudin E, Goichot B, Berruti A, Hadoux J, Moalla S, Laboureau S, Nölting S, de la Fouchardière C, Kienitz T, Deutschbein T, Zovato S, Amar L, Haissaguerre M, Timmers H, Niccoli P, Faggiano A, Angokai M, Lamartina L, Luca F, Cosentini D, Hahner S, Beuschlein F, Attard M, Texier M, Fassnacht M; ENDOCAN-COMETE; ENSAT Networks. Baudin E, et al. Among authors: laboureau s. Lancet. 2024 Mar 16;403(10431):1061-1070. doi: 10.1016/S0140-6736(23)02554-0. Epub 2024 Feb 22. Lancet. 2024. PMID: 38402886 Clinical Trial.
Surgery for the treatment of arterial hypertension in patients with unilateral adrenal incidentalomas and mild autonomous cortisol secretion (CHIRACIC): a multicentre, open-label, superiority randomised controlled trial.
Tabarin A, Espiard S, Deutschbein T, Amar L, Vezzossi D, Di Dalmazi G, Reznik Y, Young J, Desailloud R, Goichot B, Drui D, Assié G, Lefebvre H, Mai K, Castinetti F, Laboureau S, Terzolo M, Ferriere A, Georget A, Frison E, Vantyghem MC, Fassnacht M, Gosse P; CHIRACIC Collaborators. Tabarin A, et al. Among authors: laboureau s. Lancet Diabetes Endocrinol. 2025 Jul;13(7):580-590. doi: 10.1016/S2213-8587(25)00062-2. Epub 2025 May 12. Lancet Diabetes Endocrinol. 2025. PMID: 40373786 Clinical Trial.
Pregnancy and neonatal outcomes in women with GCK-MODY: an observational study based on standardised insulin modalities.
Ciangura C, Seco A, Saint-Martin C, Ancel PY, Bouvet D, Jacqueminet S, Hartemann A, Lepercq J, Nizard J, Timsit J, Bellanné-Chantelot C; Monogenic Diabetes Study Group of the Société Francophone du Diabète. Ciangura C, et al. Diabetologia. 2025 May;68(5):981-992. doi: 10.1007/s00125-025-06363-0. Epub 2025 Feb 19. Diabetologia. 2025. PMID: 39971752
Characterization, Prognosis, and Treatment of Patients With Locally Advanced or Metastatic Thymic Neuroendocrine Tumor: A Retrospective Study of the French GTE, ENDOCAN RENATEN, and RYTHMIC Networks.
Fodil-Cherif S, Hadoux J, Mercier O, Benitez JC, Durand A, Lasolle H, Perrier M, Jannin A, Laboureau S, Le Bras M, Chabre O, Gaujoux S, Rouiller LG, Hentic O, Du Boullay H, Haissaguerre M, Kinn H, Lecomte T, Goudet P, Girard N, Scoazec JY, Besse B, Faron M, Baudin E. Fodil-Cherif S, et al. Among authors: laboureau s. J Thorac Oncol. 2025 Sep;20(9):1315-1327. doi: 10.1016/j.jtho.2025.04.013. Epub 2025 May 4. J Thorac Oncol. 2025. PMID: 40328381 Free article.
Second-line treatment and prognostic factors in neuroendocrine carcinoma: the RBNEC study.
Hadoux J, Walter T, Kanaan C, Hescot S, Hautefeuille V, Perrier M, Tauveron I, Laboureau S, Do Cao C, Petorin C, Blanchet O, Faron M, Leteurtre E, Rousselet MC, Joubert Zakeyh J, Marchal A, Chatelain D, Beaulaton C, Hervieu V, Lombard-Bohas C, Ducreux M, Scoazec JY, Baudin E; Groupe d’Etude des Tumeurs Endocrines (GTE); ENDOCAN-RENATEN network. Hadoux J, et al. Among authors: laboureau s. Endocr Relat Cancer. 2022 Aug 17;29(10):569-580. doi: 10.1530/ERC-22-0102. Print 2022 Oct 1. Endocr Relat Cancer. 2022. PMID: 35920609
Cascade screening in familial hypercholesterolaemia is associated with earlier statin initiation and fewer cardiovascular events than opportunistic screening.
Mourre F, Giorgi R, Cattieuw L, Gallo A, Moulin P, Charrière S, Aouchiche K, Rigalleau V, Schiele F, Sultan A, Tounian P, Valéro R, Béliard S; REFERCHOL investigators. Mourre F, et al. Eur J Prev Cardiol. 2025 May 6:zwaf234. doi: 10.1093/eurjpc/zwaf234. Online ahead of print. Eur J Prev Cardiol. 2025. PMID: 40326712
Maternal Inheritance of Familial Hypercholesterolemia Gene Mutation Predisposes to Coronary Atherosclerosis as Assessed by Calcium Score in Adulthood.
Mourre F, Giorgi R, Gallo A, Boccara F, Bruckert E, Carrié A, Hankard R, Inamo J, Laboureau S, Moulin P, Valéro R, Béliard S; REFERCHOL Investigators. Mourre F, et al. Among authors: laboureau s. Arterioscler Thromb Vasc Biol. 2023 Feb;43(2):e94-e103. doi: 10.1161/ATVBAHA.122.318119. Epub 2022 Dec 29. Arterioscler Thromb Vasc Biol. 2023. PMID: 36579650 Free article.
Recurrence-Free Survival Analysis in Locally Advanced Pheochromocytoma: First Appraisal.
Moog S, Castinetti F, DoCao C, Amar L, Hadoux J, Lussey-Lepoutre C, Borson-Chazot F, Vezzosi D, Drui D, Laboureau S, Raffin Sanson ML, Lamartina L, Pierre P, Batisse Ligner M, Hescot S, Al Ghuzlan A, Renaudin K, Libé R, Laroche S, Deniziaut G, Gimenez-Roqueplo AP, Jannin A, Leboulleux S, Guerin C, Faron M, Baudin E. Moog S, et al. Among authors: laboureau s. J Clin Endocrinol Metab. 2021 Aug 18;106(9):2726-2737. doi: 10.1210/clinem/dgab202. J Clin Endocrinol Metab. 2021. PMID: 33782697
[Thyroid dysfunction and pregnancy].
Rodien P, Coutant R, Vasseur C, Bourdelot A, Laboureau S, Rohmer V. Rodien P, et al. Among authors: laboureau s. Rev Prat. 2005 Jan 31;55(2):174-9. Rev Prat. 2005. PMID: 15825998 Review. French.
20 results